0001209191-21-040339.txt : 20210614
0001209191-21-040339.hdr.sgml : 20210614
20210614182537
ACCESSION NUMBER: 0001209191-21-040339
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20210610
FILED AS OF DATE: 20210614
DATE AS OF CHANGE: 20210614
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ROCHE ROBERT P JR
CENTRAL INDEX KEY: 0001210193
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-32302
FILM NUMBER: 211016031
MAIL ADDRESS:
STREET 1: 41 MOORES ROAD
CITY: FRAZER
STATE: PA
ZIP: 19355
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ANTARES PHARMA, INC.
CENTRAL INDEX KEY: 0001016169
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 411350192
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 PRINCETON SOUTH
STREET 2: SUITE 300
CITY: EWING
STATE: NJ
ZIP: 08628
BUSINESS PHONE: 609-359-3020
MAIL ADDRESS:
STREET 1: 100 PRINCETON SOUTH
STREET 2: SUITE 300
CITY: EWING
STATE: NJ
ZIP: 08628
FORMER COMPANY:
FORMER CONFORMED NAME: ANTARES PHARMA INC
DATE OF NAME CHANGE: 20060120
FORMER COMPANY:
FORMER CONFORMED NAME: ANTARES PHARMA INC
DATE OF NAME CHANGE: 20020520
FORMER COMPANY:
FORMER CONFORMED NAME: ANTARES PHARMA INC /MN/
DATE OF NAME CHANGE: 20010604
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-06-10
0
0001016169
ANTARES PHARMA, INC.
ATRS
0001210193
ROCHE ROBERT P JR
C/O ANTARES PHARMA, INC.
100 PRINCETON SOUTH, SUITE 300
EWING
NJ
08628
1
0
0
0
Common Stock
2021-06-10
4
A
0
25452
4.42
A
167817
D
Stock Option (right to buy)
4.42
2021-06-10
4
A
0
48542
0.00
A
2031-06-10
Common Stock
48542
48542
D
Represents grant of restricted stock units made under the Antares Pharma, Inc. Equity Compensation Plan. The shares vest one year from the grant date.
Represents grant of options to purchase shares of common stock, par value $0.01 per share, issued under the Antares Pharma, Inc. Equity Compensation Plan.
The options vest and become exercisable one year from the grant date.
/s/ Lisa M. Kallebo as attorney-in-fact for Robert Roche
2021-06-14
EX-24.4_992667
2
poa.txt
POA DOCUMENT
POWER OF ATTORNEY
KNOW ALL PERSONS BY THESE PRESENTS, that I, Robert P. Roche, Jr., hereby
constitute and appoint Fred M. Powell, Peter J. Graham, Lisa M. Kallebo and
Keith Muckenhirn, each of them, my true and lawful attorneys-in-fact and agents,
each acting alone, with full powers of substitution and resubstitution for me
and in my name, place and stead, to sign any reports on Form 3 (Initial
Statement of Beneficial Ownership), Form 4 (Statement of Changes in Beneficial
Ownership of Securities) and Form 5 (Annual Statement of Changes in Beneficial
Ownership) relating to transactions by me in Common Stock or other securities of
Antares Pharma, Inc., and all amendments thereto, and to file the same with the
Securities and Exchange Commission and appropriate securities listing agency, if
required, granting unto said attorneys-in-fact and agents, and each of them, or
their substitutes, full power and authority to do and perform each and every act
and thing requisite or necessary to be done, as fully to all intents and
purposes as I might or could do in person, hereby ratifying and confirming all
that said attorneys-in-fact and agents, and each of them, or their substitutes,
may lawfully do or cause to be done by virtue hereof. This Power of Attorney
shall be effective until such time as I deliver a written revocation thereof to
my above-named attorneys-in-fact and agents.
/s/ Robert P. Roche
Dated: June 8, 2021